{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:troplasminogen alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02289950: Phase 2 Interventional Completed Platinum-Sensitive Ovarian Cancer in First Relapse
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01605396: Phase 2 Interventional Completed Breast Neoplasms
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03078400: Phase 1 Interventional Unknown status Ovarian Epithelial Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00873756: Phase 1 Interventional Completed Metastatic Colorectal Cancer
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01941537: Phase 2 Interventional Completed Atopic Dermatitis
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00278187: Phase 2 Interventional Unknown status Lung Cancer
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01371305: Phase 2 Interventional Completed Idiopathic Pulmonary Fibrosis (IPF)
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00104078: Phase 1/Phase 2 Interventional Completed Becker Muscular Dystrophy
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00103558: Phase 1/Phase 2 Interventional Completed Chronic Lymphocytic Leukemia
(2004)
Source URL:
Class:
PROTEIN
